ATF3 and ovarian cancer: To commence our investigation, we added lysophosphatidic acid (5 μM) to SKOV-3 ovarian cancer cells and measured an increase in ATF3 protein levels (Fig 1A) and ATF3 mRNA transcripts (Fig 1B), over 8 h.